Highlights Maravai LifeSciences Holdings, Inc.

Equities

MRVI

US56600D1072

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-10 EDT			5-day change	1st Jan Change
10.46 ^USD	+6.09%		+16.61%	+59.69%

05-09	UBS Raises Price Target on Maravai LifeSciences to $8.50 From $6.50, Maintains Neutral Rating	MT
05-09	Baird Adjusts Price Target on Maravai LifeSciences to $10 From $8, Keeps Outperform Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Reports Q1 Revenue $64.2M, vs. Street Est of $60.5M	05-08	MT
Maravai LifeSciences Holdings, Inc. Reaffirms Financial Guidance for the Full Year 2024	05-08	CI
Maravai LifeSciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
Maravai LifeSciences Unit Opens New Manufacturing Facility in San Diego	04-18	MT
Maravai LifeSciences Shares Surge After Price Target Raises, Q4 Beat	02-23	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday	02-23	MT
Maravai LifeSciences' Q4 Adjusted Earnings, Revenue Decline	02-23	MT
Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Reports Q4 Revenue $74.1M, vs. Street Est of $64.3M	02-22	MT
Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Posts Q4 EPS $0.01, vs. Street Est of $-0.01	02-22	MT
Maravai LifeSciences Holdings, Inc. Provides Earnings Guidance for the Fiscal Year 2024	02-22	CI
Maravai LifeSciences Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-22	CI
Dyadic International Partners With Maravai LifeSciences' Cygnus Technologies Unit on HCP Assay	02-13	MT
Maravai LifeSciences Holdings Seeks Acquisitions	11-07	CI
Maravai LifeSciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07	CI
Maravai LifeSciences Holdings, Inc. Provides Updated Earnings Guidance for the Full Year 2023	11-07	CI
TriLink BioTechnologies Expands Capabilities with Launch of 'Analytical Sciences Center of Excellence'	11-02	CI
Maravai LifeSciences Says Targeting $700 Million in Revenue in 2028	23-09-29	MT
Maravai LifeSciences Holdings Reports Q2 Breakeven Adjusted Earnings, Lower Revenue; Cuts Full Year Guidance	23-08-07	MT
Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Posts Q2 Revenue $68.9M, vs. Street Est of $71.1M	23-08-07	MT
Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Reports Q2 EPS $0.00, vs. Street Est of $0.01	23-08-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Maravai LifeSciences Holdings, Inc.

Equities

MRVI

US56600D1072

Highlights

Filters